Anthera Pharmaceuticals Inc (OTC Pink - No Information:ANTH)
| 0.1155 Delayed Data As of Feb 24 |  -0.0545 / -32.06%Today’s Change | 0.01 Today|||52-Week Range 0.19 | +381.25% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2014 | 2015 | 2016 | 2017 | |||
| Operating Activities | Net Income / Starting Line | -29.6M | -35.2M | -55.5M | -26.9M | |
| Depreciation | 344.0K | 285.0K | 266.0K | 281.0K | ||
| Total Other Cash Flow | 3.6M | 3.5M | 5.0M | -5.3M | ||
| Funds From Operations | -25.6M | -31.4M | -50.3M | -31.9M | ||
| Funds From/For Other Operating Expenses | -39.0K | -487.0K | -1.3M | 5.0M | ||
| Net Cash Flow - Operating Activities | -25.6M | -30.9M | -48.9M | -36.9M | ||
| Investing | Capital Expenditures | 0.00 | -80.0K | -766.0K | 0.00 | |
| Other Investing - Sources | 10.0M | 0.00 | 0.00 | 0.00 | ||
| Net Cash Flow Investing | 10.0M | -80.0K | -766.0K | 0.00 | ||
| Financing | Short Term Borrowings | 0.00 | -- | 0.00 | 0.00 | -- |
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Long Term Debt Reduction | -18.1M | 0.00 | 0.00 | 0.00 | ||
| Net Proceeds Stock Sale | 10.4M | 75.3M | 23.6M | 18.3M | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | 0.00 | -- | -- | -- | -- | |
| Cash Dividends Paid - Total | 0.00 | -- | -- | -- | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Cash Flow - Financing | -7.7M | 75.3M | 23.6M | 18.3M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | 0.00 | -- | -- | -- | -- |
| Net Change In Cash | -23.3M | 44.3M | -26.1M | -18.6M | ||
